AngioDynamics Inc (ANGO)
7.155
-0.26
(-3.44%)
USD |
NASDAQ |
Nov 07, 16:00
7.155
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Revenue (Annual): 303.91M for May 31, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| May 31, 2024 | 303.91M |
| May 31, 2023 | 338.75M |
| May 31, 2022 | 316.22M |
| May 31, 2021 | 291.01M |
| May 31, 2020 | 264.16M |
| May 31, 2019 | 270.63M |
| May 31, 2018 | 261.66M |
| May 31, 2017 | 269.79M |
| May 31, 2016 | 353.89M |
| May 31, 2015 | 356.53M |
| May 31, 2014 | 354.42M |
| May 31, 2013 | 341.92M |
| Date | Value |
|---|---|
| May 31, 2012 | 221.92M |
| May 31, 2011 | 215.75M |
| May 31, 2010 | 216.04M |
| May 31, 2009 | 195.05M |
| May 31, 2008 | 166.50M |
| May 31, 2007 | 112.23M |
| May 31, 2006 | 78.45M |
| May 31, 2005 | 60.29M |
| May 31, 2004 | 49.06M |
| May 31, 2003 | 38.43M |
| May 31, 2002 | 30.89M |
| May 31, 2001 | 23.39M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
264.16M
Minimum
2020
338.75M
Maximum
2023
302.81M
Average
303.91M
Median
2024
Revenue (Annual) Benchmarks
| Accuray Inc | 446.55M |
| Masimo Corp | 2.048B |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 91.30M |
| Catheter Precision Inc | 0.442M |